| Autor: |
Beun GD; Eli Lilly Nederland, Medische Afdeling, Leiden. |
| Jazyk: |
Dutch; Flemish |
| Zdroj: |
Nederlands tijdschrift voor geneeskunde [Ned Tijdschr Geneeskd] 1998 Feb 21; Vol. 142 (8), pp. 392-6. |
| Abstrakt: |
In a limited number of cases, T cell based cancer immunotherapy has proven its clinical efficacy. Indications are restricted to certain haematological malignancies, relapsed after allogeneic bone marrow transplantation, and tumours against which an autologous T cell response can be elicited or boosted, such as melanomas and renal carcinomas. T cell based immunotherapy of non-immunogenic tumors is possible using bispecific antibodies. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
